Monday, February 14, 2005 12:52:43 PM
Monday February 14, 11:41 am ET
BARTLESVILLE, Okla., Feb. 14 /PRNewswire-FirstCall/ -- New Harvest Capital Corp. (OTC Bulletin Board: HVST - News; "New Harvest" or the "Company") and certain of its security holders have executed a non-binding Term Sheet with a privately-held company which is a development stage biopharmaceutical company that is focused on the development and commercialization of diagnostics and therapeutics for large populations in inflammatory diseases.
The transaction contemplated by the Term Sheet would include the merger of the target company into a wholly-owned subsidiary of New Harvest and a change of control of New Harvest. Completion of the proposed transaction is subject to various terms and conditions, including but not limited to the negotiation and execution of definitive agreements between the parties, the arrangement of financing, necessary approvals by the boards of directors and stockholders and the satisfactory completion of due diligence. The current shareholders of New Harvest would suffer substantial dilution as a result of the proposed transaction. It is currently expected that the current shareholders of New Harvest will retain approximately three to five percent of the equity in the post-merger entity. New Harvest has granted the target an exclusive period, through March 31, 2005, in which to negotiate and execute a definitive merger agreement. There is no assurance that New Harvest will be successful in negotiating and entering into a definitive merger agreement or that the transaction contemplated by the merger agreement will be completed.
_________________
If what you did yesterday isn't working, change it!!!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM